FDA Grants Fast Track Designation for AJ201, a First-in-Class Therapy for Kenndy’s Disease
TAIPEI, Oct. 22, 2025 /PRNewswire/ — AnnJi Pharmaceutical Co., Ltd. (AnnJi, TWSE: 7754) today announced…
Tag: AnnJi Pharmaceutical Co.
FDA Grants Fast Track Designation for AJ201, a First-in-Class Therapy for Kenndy’s Disease
TAIPEI, Oct. 23, 2025 /PRNewswire/ — AnnJi Pharmaceutical Co., Ltd. (AnnJi, TWSE: 7754) today announced…